P669: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 3-YEAR FOLLOW-UP FROM THE PHASE 2 CAPTIVATE STUDY FD COHORT

• C. Moreno,
• W. G. Wierda,
• P. M. Barr,
• T. Siddiqi,
• J. N. Allan,
• T. J. Kipps,
• L. Trentin,
• R. Jacobs,
• S. Jackson,
• A. Tedeschi,
• S. Opat,
• R. Bannerji,
• B. J. Kuss,
• L. J. Croner,
• E. Szafer-Glusman,
• C. Zhou,
• A. Szoke,
• J. P. Dean,
• P. Ghia,
• C. S. Tam

Affiliations

C. Moreno

1 Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona

W. G. Wierda

3 Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

P. M. Barr

4 Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

T. Siddiqi

5 City of Hope National Medical Center, Duarte, CA

J. N. Allan

6 Weill Cornell Medicine, New York, NY

T. J. Kipps

7 UCSD Moores Cancer Center, La Jolla, CA, United States of America

L. Trentin

8 University of Padova, Padova, Italy

R. Jacobs

9 Levine Cancer Institute, Charlotte, NC, United States of America

S. Jackson

10 Middlemore Hospital, Auckland, New Zealand

A. Tedeschi

11 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

S. Opat

12 Monash University, Clayton, VIC, Australia

R. Bannerji

13 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States of America

B. J. Kuss

14 Flinders University and Medical Center, Bedford Park, SA, Australia

L. J. Croner

15 AbbVie, North Chicago, IL

E. Szafer-Glusman

15 AbbVie, North Chicago, IL

C. Zhou

16 Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, United States of America

A. Szoke

16 Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, United States of America

J. P. Dean

16 Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, United States of America

P. Ghia

17 Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy

C. S. Tam

18 Peter MacCallum Cancer Center & St. Vincent’s Hospital and the University of Melbourne, Melbourne, VIC, Australia